FDA Drug Application (018833) for LITHANE by BAYER PHARMS

Back to FDA Applications sponsored by BAYER PHARMS

Application Number018833
Product Number001
FormTABLET;ORAL
Dosage300MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLITHANE
Active IngredientLITHIUM CARBONATE

Active IngredientCount
List of drugs with Active Ingredient LITHIUM CARBONATE7


Back to FDA Applications sponsored by BAYER PHARMS